Medical Device:

NuvaRing

Manufactured by Organon, NuvaRing is a widely used form of pregnancy prevention. NuvaRing is placed near the cervix and releases a steady dose of synthetic hormones. For 21 days, NuvaRing releases etonogestrel and ethinyl estradiol. The birth control device is then removed for the woman’s menstrual cycle and replaced after several days. The hormones administered by NuvaRing prevent ovulation and limit sperm penetration. However, NuvaRing has been linked to serious side effects including blood clots, heart attacks, strokes and pulmonary embolisms.

Like the Ortha Evra patch, NuvaRing does not require a strict daily regimen like the pill. Unfortunately, NuvaRing has been the center of much controversy as it has been linked to more than 12 deaths. Many women using NuvaRing experienced blood clots, which are likely induced by the high levels of estrogen and progestin released into the body. Blood clots can be very hazardous to a woman’s health, causing serious injury and even death. In some instances, blood clots have lead to pulmonary embolisms, which can necessitate amputations or cause death.

Lawsuits are alleging that Organon and Schering Plough were aware of the risk of strokes, toxic shock syndrome and blood clots associated with NuvaRing, but failed to alert the public or FDA. Organon also claims the dose of hormones released by the contraceptive device is low, and fails to highlight the risk of heart problems in the warning label. Because of this, many women believe that NuvaRing is just as safe as oral contraceptives.

If you or a loved one suffered a blood clot, heart attack, stroke or other serious complication while using NuvaRing, you may be eligible for compensation. Fill out our free case review on the right to speak with a NuvaRing attorney today.

Do you think you might have a Medical Device case?
Contact our experienced Medical Device lawyers right now.